Targeted AMP generation through controlled diffusion with efficient embeddings
By: Diogo Soares , Leon Hetzel , Paulina Szymczak and more
Potential Business Impact:
Finds new germ-fighting medicines faster.
Deep learning-based antimicrobial peptide (AMP) discovery faces critical challenges such as low experimental hit rates as well as the need for nuanced controllability and efficient modeling of peptide properties. To address these challenges, we introduce OmegAMP, a framework that leverages a diffusion-based generative model with efficient low-dimensional embeddings, precise controllability mechanisms, and novel classifiers with drastically reduced false positive rates for candidate filtering. OmegAMP enables the targeted generation of AMPs with specific physicochemical properties, activity profiles, and species-specific effectiveness. Moreover, it maximizes sample diversity while ensuring faithfulness to the underlying data distribution during generation. We demonstrate that OmegAMP achieves state-of-the-art performance across all stages of the AMP discovery pipeline, significantly advancing the potential of computational frameworks in combating antimicrobial resistance.
Similar Papers
Improvement of AMPs Identification with Generative Adversarial Network and Ensemble Classification
Machine Learning (CS)
Finds new germ-fighting helpers for medicine.
A deep reinforcement learning platform for antibiotic discovery
Machine Learning (CS)
Creates new medicines to fight superbugs.
Semi-supervised Latent Bayesian Optimization for Designing Antimicrobial Peptides
Machine Learning (CS)
Finds new germ-fighting medicines faster.